No Data
No Data
With 74% Ownership, Accolade, Inc. (NASDAQ:ACCD) Boasts of Strong Institutional Backing
Press Release: Accolade to Announce Fiscal Second Quarter 2025 Financial Results
D.A. Davidson Maintains Accolade(ACCD.US) With Hold Rating
BofA Securities Maintains Accolade(ACCD.US) With Buy Rating, Announces Target Price $7
First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies
Express News | Accolade Shares Are Trading Higher Following a Report Suggesting the Company Is Exploring a Sale